Glennon R.A., McKenney J.D., Lyon R.A., Titeler M. (1986) 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem29: 194-199
3.
Handley S.L., Dursun S.M. (1992) Serotonin and Tourette's Syndrome: movements such as head-shakes and wet-dog-shakes may model human tics. Adv Biosci85: 235-253
4.
Handley S.L., Miskin R.C. (1977) The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine. Psychopharmacology51: 305-309
5.
Heaton J C P, Handley S.L. (1989) Comparison of DOI-induced scratching and head-twitch behaviours: differential action of 8-OH DPAT. Br J Pharmacol98: 687P
6.
Heyes M.P. (1993) Metabolism and neuropathological significance of quinolinic acid and kynurenic acid. Biochem Soc Trans21: 83-89
7.
Kennett G.A., Curzon G. (1991) Potencies of antagonists indicate that 5-HT 1C receptors mediate the 1-3 (chlorophenyl) piperazine-induced hypophagia . Br J Pharmacol103: 2016-2020
8.
Kennett G.A., Wood M.D., Grewal G.S., Forbes I., Gadre A., Blackburn T.P. (1994) In vivo properties of SB200646A, a 5-HT2C/2B receptor antagonist. Br J Pharmacol111: 797-802
9.
Schwarcz R. (1993) Metabolism and function of brain kynurenines. Biochem Soc Trans21: 77-82
10.
Stone T.W., Connick J.H. (1985) Quinolinic acid and other kynurenines in the central nervous system. Neurosciences15: 597-617
11.
Wolf H. ( 1974) Studies on tryptophan metabolism in man. Scand J Clin Lab Invest136 (Suppl.): 33
